Navigation Links
Genous in Medical Technology

Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents

Risk of Late Thrombosis is Minimized with Genous Stent BARCELONA, Spain, May 23, 2007 /PRNewswire/ -- The efficacy of OrbusNeich's Genous(TM) Bio-engineered R stent compares favorably to that of drug-eluting stents, while the risk of late thrombosis is minimized with the Genous stent, according to...

Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents

...ble results in patients treated with the company's genous Bio-engineered R stent, the world's first pro-heal...scularization (TLR) rates (15.3% vs 13.7%) for the genous Bio-engineered R stent compared to Boston Scientif...hromboses. There were no thrombotic events in the genous treated group at any time period (0.0%). Myocardi...

Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM)

...nd efficacy in the real-world use of the company's genous Bio-engineered R stent. Presented by Professor R...te of 8.5%. "The data further support the use of genous as an alternative to drug- eluting stents, especia...stry with 5,000 enrolled patients treated with the genous Bio-engineered R stent. The study protocol recomme...

Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008

... the world's first pro-healing stent, OrbusNeich's genous Bio-engineered R stent, will be presented next wee...cademic Medical Center in Amsterdam will provide a genous clinical program update in an oral presentation at...a Real World Experience in Patients Treated with a genous EPC Capturing Stent," the poster will reflect the ...

Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents

... of Interventional Cardiology demonstrate that the genous Bio-engineered R stent has better outcomes when co...percutaneous coronary intervention with either the genous stent or a TAXUS(R) and CYPHER(R) stent at the uni...rsus 5.8% for DES. "Our results suggest that the genous Bio-engineered R stent is safe and effective in hi...

Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents

...m at EuroPCR 2008 support the use of the company's genous Bio-engineered R stent, the world's first pro-heal...(TVF) rates at 12-month follow-up for OrbusNeich's genous Bio-engineered R stent and Boston Scientific's Tax...events, while there were no reported events in the genous group. TRIAS HR Pilot is a randomized, 193-patient...

Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008

...nth follow up data on 78 patients treated with the genous stent. Jonathan Hill, M.D., of King's College, L...Hospital, Singapore will present on the use of the genous Bio-engineered R stent in acute myocardial infarct... single blind study called TRIAS HR Pilot with the genous stent randomized with a drug eluting stent. In add...

Clinical Impact of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology

... of the first-ever pro-healing stent, OrbusNeich's genous Bio-engineered R stent, is the subject of a sympos....-1:35 p.m. -- The latest clinical update on the genous technology by Federico Piscione, M.D., of Fede... on the data we've seen with the real-world use of genous and in recent clinical trials, we believe that the...

OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial

...s who received OrbusNeich's pro-healing stent, the genous Bio-engineered R stent, had significantly fewer ma...ES. "Our findings suggest that the deployment of genous stents in a consecutive series of high-risk patien...otoxic agents to inhibit neointimal proliferation, genous attracts circulating endothelial progenitor cells ...

Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) and Boston Scientific's Taxus(R) Stent in Patients at High Risk of Restenosis

...follow-up, the majority of patients who received a genous stent were on single antiplatelet therapy, whi... therapy -- One acute stent thrombosis in the genous arm, while there was one acute, one subacute ... for the large-scale TRIAS study that will compare genous to both drug-eluting and bare metal stents." For ...
Genous in Biological Technology

OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients

...arget lesion revascularization (TLR) rate with the genous treated patient group compared with patients recei...mbosis events at any time period in the 98 patient genous group with only one month of dual antiplatelet the...e composite of death and myocardial infarction for genous was 4.1% versus 7.3% for Taxus. "Within a month w...

Interim Analysis of Data from e-HEALING Registry of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at AHA Scientific Sessions 2008

...om e-HEALING, a global post-marketing surveillance registry of OrbusNeich's genous Bio-engineered R stent, will be presented next week at the American Heart A...reatment of vascular diseases. The company's product portfolio includes the genous Bio-engineered R stent, an antibody-coated device that is the first-ever st...

OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports

...rnal (2008; Vol. 155, Issue 1: 128-132). The paper, based on a study of 120 acute ST-elevation myocardial infarction (STEMI) patients who received a genous stent, reports there was no incidence of late thrombosis and that the revascularization rate of 2.5% at six months is highly acceptable when compared ...
Other Tags
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Measures taken ... plantation in Ebola-ravaged Liberia may have limited the spread ... researchers report. The Firestone Natural Rubber Co. provides ... and residents of nearby densely populated communities. Between ... and suspected Ebola cases among those 80,000 people. That ...
(Date:10/20/2014)... Texas (PRWEB) October 20, 2014 The ... the must-have source of thousands of facts, figures and ... countries and 68 medical sector forecast categories the ... with global, regional and national views on the worldwide ... outlook. , The report gives you data for 2010-2019, ...
(Date:10/20/2014)... 2014 The Advocator Group, LLC ... the American Foundation for Suicide Prevention’s (AFSP) Out of ... a not-for-profit organization that hosts hundreds of community walks ... events are used to help understand and prevent suicide ... relationships as well. , The Advocator Group shares ...
(Date:10/20/2014)... T.E.N., a technology and information ... that William H. Murray, renowned author and industry ... Leadership Award winner. Presented annually, the ISE® Luminary ... leader and industry practitioner for his or her ... information security industry. , Formerly with IBM, Murray ...
(Date:10/20/2014)... Angeles, CA (PRWEB) October 20, 2014 ... fitness expertise, nutritional coaching, corporate wellness programming, authorship, international ... CPT, is excited to announce the release of the ... , After many years of coaching thousands of individuals ... nutrition tracking app that does not require calorie counting ...
Breaking Medicine News(10 mins):Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3
(Date:10/19/2014)... electricity access in India over the last 30 ... carbon emissions growth during that time, according to ... Nature Climate Change ., "Energy access is fundamental ... of life, including education, communication, and health," says ... , While increased energy access is widely agreed ...
(Date:10/18/2014)... a group of 2,000 patients referred for evaluation ... potential molecular diagnosis for 25 percent, including detection ... new mutations contributing to disease, according to a ... is being released to coincide with the American ... sequencing analyzes the exons or coding regions of ...
(Date:10/17/2014)... – Accurate knowledge regarding Ebola is critical and pertinent ... of hazardous global outbreak and epidemic. The Journal, ... a special issue, Ebola Virus and Public Health, to ... knowledge in this critical societal moment. , On ... Ebola for Clinicians . The primer was prepared by ...
Breaking Biology News(10 mins):Improved electricity access has little impact on climate change 2Whole-exome sequencing shows potential as diagnostic tool 2
Other Contents